Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor... (lopment market. With the total outsourci...)

Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event

Date:8/22/2007

lopment market. With the total outsourcing market opportunity estimated to reach between $17.8 and $19.6 billion globally in 2007 and between $25.9 and $29.6 billion by 2010, our future has never been more promising. As our customers continue to embrace outsourcing as a strategic approach to decrease costs and gain efficiencies in their drug development efforts we anticipate they will turn increasingly to CROs like Kendle that provide global patient access, medical and therapeutic expertise and experienced clinical development teams to deliver their global clinical trials.

"In this era of great opportunity Kendle continues to grow above the market rate, demonstrating our customers' increasing recognition of us as a proven global drug development partner able to connect experienced resources worldwide across multiple therapeutic areas and geographies to solve their clinical development challenges. Our growing global footprint and strength in emerging regions such as Central and Eastern Europe and Latin America, deeply valued by our customers, is demonstrated by the fact that Kendle is now one of only two global CROs to have at least 50 percent of its revenue outside the United States." Dr. Kendle concluded, "As we look to the future we believe that advances in science will result in even greater opportunities for globally connected and experienced CROs with expertise in multiple therapeutic areas, regions and eClinical technologies. We look forward to capitalizing on these exciting opportunities and to the increasing role Kendle will play in making life-saving drugs a reality for patients around the globe."

10 Years of Growth

-- Kendle today is among the world's leading CROs and is the fourth-

largest provider of Phase II-IV clinical development services

worldwide.

-- Kendle has grown from 500 associates in eight locations in August 1997

to more than 3,000 associates today in 48 offices across 26 countries

o
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Summer marks countdown to DEMOfall
2. Digital Healthcare Conference marks Wisconsins Healthcare IT Week
3. Biomedical alliance marks first full year
4. Bone Care marks solid quarter on Hectorol sales jump
5. Global branding is easy with global trademarks
6. Furious pace of Midwest biotech events marks progress
7. SupraNet marks off 10 years as an Internet service provider
8. Recent developments in the protection of trademarks on the Internet
9. High Tech Happy Hour will mark fourth anniversary
10. Its All Fun And Games in Madison - Raven Software Celebrates 15 Anniversary
11. 2006: A great biotech financing year, unless you were going public!

Post Your Comments:

Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor...(lopment market. With the total outsourci...)